Abstract. The mathematical theory of single outbreak epidemic models really began with the work of Kermack and Mackendrick about 8 decades ago. This gave a simple answer to the long-standing question of why epidemics woould appear suddenly and then disappear just as suddenly without having infected an entire population. Therefore it seemed natural to expect that theoreticians would immediately proceed to expand this mathematical framework both because the need to handle recurrent single infectious disease outbreaks has always been a priority for public health officials and because theoreticians often try to push the limits of exiting theories. However, the expansion of the theory via the inclusion of refined epidemiological classifications or through the incorporation of categories that are essential for the evaluation of intervention strategies, in the context of ongoing epidemic outbreaks, did not materialize. It was the global threat posed by SARS in 2003 that caused theoreticians to expand the Kermack-McKendrick single-outbreak framework. Most recently, efforts to connect theoretical work to data have exploded as attempts to deal with the threat of emergent and re-emergent diseases including the most recent H1N1 influenza pandemic, have marched to the forefront of our global priorities. Since data are collected and/or reported over discrete units of time, developing single outbreak models that fit collected data naturally is relevant. In this note, we introduce a discrete-epidemic framework and highlight, through our analyses, the similarities between single-outbreak comparable classical continuoustime epidemic models and the discrete-time models introduced in this note. The emphasis is on comparisons driven by expressions for the final epidemic size.
Dedicated to Horst R. Thieme on the Occasion of his 60th Birthday
Abstract. The mathematical theory of single outbreak epidemic models really began with the work of Kermack and Mackendrick about 8 decades ago. This gave a simple answer to the long-standing question of why epidemics woould appear suddenly and then disappear just as suddenly without having infected an entire population. Therefore it seemed natural to expect that theoreticians would immediately proceed to expand this mathematical framework both because the need to handle recurrent single infectious disease outbreaks has always been a priority for public health officials and because theoreticians often try to push the limits of exiting theories. However, the expansion of the theory via the inclusion of refined epidemiological classifications or through the incorporation of categories that are essential for the evaluation of intervention strategies, in the context of ongoing epidemic outbreaks, did not materialize. It was the global threat posed by SARS in 2003 that caused theoreticians to expand the Kermack-McKendrick single-outbreak framework. Most recently, efforts to connect theoretical work to data have exploded as attempts to deal with the threat of emergent and re-emergent diseases including the most recent H1N1 influenza pandemic, have marched to the forefront of our global priorities. Since data are collected and/or reported over discrete units of time, developing single outbreak models that fit collected data naturally is relevant. In this note, we introduce a discrete-epidemic framework and highlight, through our analyses, the similarities between single-outbreak comparable classical continuoustime epidemic models and the discrete-time models introduced in this note. The emphasis is on comparisons driven by expressions for the final epidemic size.
2000 Mathematics Subject Classification. Primary: 92D25, 92D30; Secondary: 34C60, 39A05. Key words and phrases. epidemic, final size, single outbreak, discrete epidemic models, continuous time epidemic models.
The first author is partially supported by NSERC, and the second author is partially supported by NSF grant DMS-0719697. 
1.
Introduction. The study of compartmental epidemic models, in the context of single-epidemic outbreaks, began with the work of Kermack and McKendrick [23] . Traditionally, mathematical epidemiology has been driven by a continuoustime perspective in deterministic or stochastic settings [2, 5, 7, 10, 20] [14, 19, 28] also generated additional theoretical work on single epidemic outbreak models [9] . The analytical emphasis, as in the original work of Kermack and McKendrick, has been on the computation of expressions for the final epidemic size. Computation of a general expression for the final size relation, in the context of multiple modeling frameworks, requires computation of the basic reproduction number. Some aids for this computation can be found in [9, 15, 27, 29] .
Most of the models studied have been continuous in part because these are more tractable mathematically. A good reason for studying discrete models is that data are collected at discrete times and hence it may be easier to compare data with the output of a discrete model. Furthermore, the numerical exploration of discrete-time epidemic models is rather straightforward and therefore can be easily implemented by non-mathematicians, an advantage in the public health world. There has been some study of discrete disease transmission models with births and natural deaths [1, 3, 4, 11, 12, 13, 24] , but to our knowledge the only discrete epidemic study is [30] . The overall goal of this note is to contrast in setting of epidemiological interest the methods and approaches used to compute the final epidemic relation in continuous and discrete-time settings. The age of infection approach does not lend itself to discrete models but it is possible to give discrete versions of staged progression and differential infectivity epidemic models as well. Hence, the specific purpose of this note is twofold, namely, to extend the calculation of the basic reproduction number and the final size of an epidemic to general continuous staged progression and differential infectivity models for both discrete and continuous time models [21, 22] . We develop this theory, showing how to calculate the basic reproduction number and the final size of an epidemic. We assume throughout that there are no disease, deaths, so that the total population size remains constant.When disease deaths are significant then the final size relation is given by an inequality, that is, we can not be calculate the final size of an epidemic exactly. However, if the disease death rate is small, the final size relation is an approximate equality, and may be used to obtain good estimates of the final size.
The rest of this paper is organized as follows: Section 2 focuses on the study of continuous staged-progression, single outbreak, epidemic models, with the primary result being the computation of the final size relationship; the impact of treatment, at multiple levels, in the context of the model of Section 2 is explored and a final size relation is computed in terms of the _ control reproductive number in Section 3; Section 4 introduces a discrete-time epidemic model, that includes discrete stage progression, and computes the final epidemic size relation as a function of the basic reproductive number; Section 5 focuses on treatment and the computation of a final size relationship as a function of the control reproductive number; In Section 6, we collect some observations and conclusions.
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2. The continuous staged progression epidemic. We consider an epidemic with progression from S through k infected stages I 1 , I 2 , · · · , I k . We assume that in stage i the relative infectivity is ε i , the distribution of stay in the stage is given by P i with P i (0) = 1, ∞ 0 P (t)dt < ∞, and P i monotone non-decreasing. There are no disease deaths and the total population size N is constant. We assume initial conditions
The total infectivity is given by
and
We let B i (t) denote the input to stage i at time t, so that
Then
and this implies
from which we calculate
Next,
The epidemic model consists of the equations (1), (2), and (3). Differentiation of (3) gives
and the input B 2 (t) to stage 2 is
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We now see that
Integration of (2) gives
Integration of (3) gives
Combining (2) and (3) we have
Integration of (1) gives
this takes the familiar final size relation form
3. Treatment models. We consider two alternatives for treatment. The first is treatment at the beginning of a stage, with a specified fraction of individuals entering the stage being selected for treatment and moving to a treatment compartment. The second is treatment throughout a stage, with a rate of transfer from the untreated compartment to a treatment compartment.
3.1. Treatment at the beginning of a stage. To the model given by (1), (2), (3) we add treatment at the beginning of each stage. By this, we mean that a fraction p 1 of members of S who are infected go to a treatment compartment T 1 while the remaining fraction q 1 of newly infected members go to I 1 . There is a sequence T 1 , T 2 , · · · , T n of treated compartments with relative infectivity δ i and period distribution Q i in T i . Treated members continue through the treatment stages. In addition, of the members leaving an infected stage I i , a fraction p i enters treatment in T i+1 while the remaining fraction q i continues to I i+1 . We let m i denote the fraction of infected members who go through the stage I i and n i the fraction of infected members who go through the stage T i . Then
The total infectivity is now
and we have
We use R c in place of R 0 to indicate that this is a control reproduction number. The final size relation takes the expected form
The calculation of the control reproduction number takes a simpler form if treatment takes place in only one stage, say at the beginning of stage j. Then p 1 = 0 if i = j, and
It would be more realistic to consider a model in which members are moved from an infective class I i to a treated class T i rather than being designated for treatment at the beginning of the stageI i . However, the mathematical analysis of this situation is more complicated.
Treatment throughout
The equation (1) is unchanged, but now
Differentiation of (10) gives
With the aid of integration by parts, we see that
In place of (2) we now have
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Integration by parts gives
and we define
Using (11) we see by induction that
The equation
A similar calculation leads to
Because of (13) we have
Next, we write
The epidemic model consists of the equations (1), (10), (12) , and (15). Differentiation gives
The output from
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We now obtain
It is convenient to write
Combination of (14) and (16) gives the control reproduction number
and the same final size relation (9) . The results take a much simpler form if treatment is confined to a single stage.
This leads to
4. Discrete epidemic models. We begin with the simplest discrete epidemic model, the discrete analogue of the simple continuous epidemic model
We define the function G(S, I) = e −βI , and let
In this model G k is the fraction of susceptibles at stage k who remain susceptible to stage (k + 1), and σ is the fraction of infectives at each stage who remain infective to the next stage. It is clear that
Since G k ≤ 1, S k is a decreasing sequence and has a limit S ∞ ≥ 0 as t → ∞. Since σ ≤ 1, S k+1 + I k+1 is a decreasing sequence and has a limit S ∞ + I ∞ as t → ∞. Also, the difference of successive terms in this sequence −(1 − σ)I k tends to zero, and this shows that I ∞ = 0. In order to show, as for the continuous epidemic model, that S ∞ > 0, we proceed as follows. It is easy to show by induction that
Because ln G j = −βI j , this gives
We let k → ∞, and
From (19) we have S k − S k+1 = I k+1 − σI k , and summing over k we have
Using N = S 0 + I 0 and combining (21) and (22), we have
Because the mean infective period is
the basic reproduction number is
the final size relation becomes
4.1. The discrete staged progression epidemic. Let I (i) j denote the fraction of infected in stage i (i = 1, 2, · · · , k) at time j. We assume initial conditions
Consider the system
where
From the S equation in (24) we have
Thus,
From (25) we have
Thus, (26) can be written as
We let n → ∞ and obtain
From the I (1) equation in (24) and using S j G j = S j+1 , we have
and taking summation on both sides:
Assume that I
n+1 → 0 as n → ∞. Taking the limit n → ∞ in the above equation and using S 0 + I 0 = N we have
Using the I (i) equation in (24) for i ≥ 2, and noticing that I (i) 0 = 0, we can get
From (29) and (30) we have
Substituting (31) into (28) we get
Since the reproduction number is
we obtain
5. Discrete treatment models. For discrete epidemic models we think of events occurring only at discrete times, and the selection of members for treatment occurs only at the beginning of a stage. Let I j+1 while the remaining fraction q i continues to I i+1 . We let m i denote the fraction of infected members who go through the stage I i and n i the fraction of infected members who go through the stage T i . Then, as in the continuous case,
We use initial conditions
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The treatment system is
(1)
with
From the S equation in (35) and similarly to the case of no treatment we can obtain
Using the I (1) equation in (35) we have (assuming again that I
Using the I (i) equation in (35) we have
which leads to
Using (37) and m i = q i q i−1 · · · q 1 (with m 0 = 1) we rewrite (38) as
Using the T (1) equation in (35) we have
Using the T (i) equation in (35) we have
Thus, using
Substituting (39) and (41) into (36) we get
Let
then the equation (42) becomes
6. Conclusions. The SARS epidemic of 2003 brought to our attention the importance of developing theory that would allow us to test the impact of intervention policies in the context of single-epidemic outbreaks. Theoreticians had been 'distracted' from this important task putting emphasis on the study of the long-term (asymptotic) dynamics of epidemic models (models that include vital dynamics) for which there is a rich mathematical theory. Hence, the theoretical emphasis had been on the study of endemic behavior or on the identification of mechanisms that would generate 'non-typical' long-term dynamics, like oscillations. Furthermore, the exploration of the impact of control measures had as its driving goal the elimination or eradication of a disease via long-term policies that focus primarily on the evaluation of vaccination or education long-term policies [20] . The SARS epidemic [14, 19, 28] , fears of the avian flu [6, 16, 17, 18, 25, 26] and the most recent H1N1 pandemic have brought to the forefront the importance of having a theory that allow us for the exploration of measures that can contain, in real time, single epidemic outbreaks [6, 8, 16, 17, 18, 25, 26] In this note, we present elements of this theory in the context of discrete and continuous-time single outbreak models with some degree of epidemiological heterogeneity. Specifically, we have extended the simple continuous epidemic model to include staged progression models and have developed the analogous results for discrete epidemic models. The basic results on reproduction numbers have analogues for discrete models, and the final size relations discrete models for discrete models are identical to those for continuous models. However, important and obvious challenges remain. The most critical has to do with finding a theory that manages to deal with single epidemic outbreaks in the context of meta-populations. In other words, dealing with realistic levels of heterogeneity, particularly those driven by the movement of people between different environments or communities or incorporating the role of behavior in single-outbreak models has yet to be carried out.
